None listed
Conditions
Interventions
Intervention1: Hair Oil 3: Product A: Approx. 2-4 ml of given product is to be applied on scalp and hair shaft thrice a week. for period of 28 days.
Control Intervention1: NIL: NIL
Sponsors
Kama Ayurveda Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Having moderate to severe hair fall. 2. Having Moderate to severe dandruff (where 0 is None, 1 is Slight, 2 is Mild, 3 is Moderate, 4 is Severe) 3. Suffering with hair thinning on subject assessment basis. For female: Having at least shoulder length hair. Having washed their hair with provided neutral shampoo, 48 hours before the first day of the study with the provided nuetral shampoo. Having untangled their hair at home, 3 hours prior coming to the site for observations, the first day of the study.
Exclusion criteria
Exclusion criteria: 1. Small, red bumps on the scalp, neck, and shoulders (bumps may become crusty and ooze). 2. Subject having applied a product with an anti-hair fall claim (due to breakage)or anti dandruff claim in the 2 weeks preceding the start of the study. 3. Having surgery history on the scalp (micro transplants â?¦) 4. In the previous 6 months, Having undergone the Minoxidil treatments, Antiandrogen medicine (cyproterone acetate, spironolactone, flutamide), Having undergone one of the following treatments known to : induce hair loss : retinoids, anti coagulants, anti-convulsive drugs, chemotherapy, beta-blocking agents, non steroidal anti inflammatory drugs, corticoids,Having modified her hormonal contraception. 5. In the previous 3 months, Having undergone a local or general anti hair loss treatment (Biotine, dexpanthenol, sulphur amino-acid, B6 vitamin, zinc), Having taken a food supplement with an anti hair loss claim, Having taken an iron based treatment 6. In the previous 15 days, Having applied a product with an anti hair loss claim (due to breakage) or anti dandruff claim
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Hair Fall, Reduction in Anti-dandruff effectTimepoint: T0, 14 days and 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety on skinTimepoint: T0, 14 days and 28 days | — |
Countries
India
Contacts
Public ContactMr Mohit Lalvani
MASCOT-SPINCONTROL India Pvt. Ltd.
Outcome results
None listed